Literature DB >> 2563316

Does choice of anesthetic agent significantly affect outcome after coronary artery surgery?

K J Tuman1, R J McCarthy, B D Spiess, M DaValle, R Dabir, A D Ivankovich.   

Abstract

A prospective study of 1094 consecutive adult patients undergoing coronary revascularization was undertaken to determine the effect of anesthetic technique on outcome. Patients received one of five primary techniques: high-dose fentanyl (greater than 50 micrograms/kg), moderate-dose fentanyl (less than 50 micrograms/kg), sufentanil (3-8 micrograms/kg), diazepam (0.4-1 mg/kg) with ketamine (3-6 mg/kg) or halothane (0.5-2.5% inspired concentration after thiopental induction). Supplemental inhalation anesthesia (enflurane, halothane, or isoflurane) was used in 60% of cases where the primary technique was intravenous based. Patients in the above anesthetic groupings had similar perioperative demographic and risk classifications. The overall incidence of postoperative myocardial infarction, postoperative low cardiac output state, and in-hospital death were 4.1, 5.6, and 3.1%, respectively. There were no significant differences in the incidence of these occurrences or in the incidence of serious pulmonary, renal, or neurologic morbidity or length of ICU stay among primary anesthetic techniques nor among supplemental inhalation agent groups. Multivariate discriminant analysis of this data suggests that a multitude of factors are significantly more important than anesthetic technique as determinants of outcome after coronary artery surgery.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2563316     DOI: 10.1097/00000542-198902000-00003

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

1.  Nitrous oxide 1844-1990.

Authors:  J P O'Connor
Journal:  Can J Anaesth       Date:  1990-09       Impact factor: 5.063

2.  Anaesthesia training and development in Nepal 1985-1990.

Authors:  J R Maltby; R Amatya; N B Rana; B M Shrestha; T M Tuladhar; T J McCaughey
Journal:  Can J Anaesth       Date:  1991-01       Impact factor: 5.063

Review 3.  The patient with heart disease.

Authors:  J Ramsay
Journal:  Can J Anaesth       Date:  1996-05       Impact factor: 5.063

4.  Comparison of sevoflurane/fentanyl and isoflurane/fentanyl during elective coronary artery bypass surgery. Sevoflurane Venture Group.

Authors:  N R Searle; R J Martineau; P Conzen; A al-Hasani; L Mark; T Ebert; M Muzi; L R Hodgins
Journal:  Can J Anaesth       Date:  1996-09       Impact factor: 5.063

5.  Ketamine concentrations during cardiopulmonary bypass.

Authors:  R F McLean; A J Baker; S E Walker; C D Mazer; B I Wong; E M Harrington
Journal:  Can J Anaesth       Date:  1996-06       Impact factor: 5.063

Review 6.  Perioperative stroke. Part II: Cardiac surgery and cardiogenic embolic stroke.

Authors:  D H Wong
Journal:  Can J Anaesth       Date:  1991-05       Impact factor: 5.063

7.  Postoperative haemodynamic and pharmacological responses in patients with positive technetium pyrophosphate single-photon emission computed tomography following CABG.

Authors:  D C Cheng; R J Burns; F Chung; A Chung; C M Feindel
Journal:  Can J Anaesth       Date:  1992-01       Impact factor: 5.063

Review 8.  Practical treatment recommendations for the safe use of anaesthetics.

Authors:  J W Sear
Journal:  Drugs       Date:  1992-01       Impact factor: 9.546

Review 9.  Anaesthesia for coronary artery surgery--a plea for a goal-directed approach.

Authors:  R I Hall
Journal:  Can J Anaesth       Date:  1993-12       Impact factor: 5.063

Review 10.  Extracellular signalling molecules in the ischaemic/reperfused heart - druggable and translatable for cardioprotection?

Authors:  P Kleinbongard; G Heusch
Journal:  Br J Pharmacol       Date:  2014-11-24       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.